Did you know? Hybrid AF™ Therapy with the EPi-Sense System is the first and ONLY FDA-approved device for minimally invasive ablation therapy to treat long-standing persistent Afib—the most prevalent and undertreated Afib patient population.​
​
Visit us at <a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS&highlightedUpdate…; target='_blank'>#APHRS</a> to explore the latest clinical science and discover novel strategies for the treatment of Afib with Hybrid AF™ Therapies.​​
​
Learn more about Hybrid AF™ Therapy: <a href="https://okt.to/ib6A0W&quot; target="_blank">https://okt.to/ib6A0W</a&gt; ​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>